Bipartisan letter urges effective administration of 340B program

Aug 29, 2018 - 12:16 PM
hhs-appeal

House Energy and Commerce Committee Chairman Greg Walden, R-Ore., Energy and Commerce Committee Ranking Member Frank Pallone, Jr., D-N.J., Senate Health, Education, Labor, and Pensions Committee Chairman Lamar Alexander, R-Tenn., and Senate HELP Committee Ranking Member Patty Murray D-Wash., Aug. 27 sent a letter to the Health Resources and Services Administration urging the agency to use its existing rulemaking authority to implement regulations to better administer the 340B drug savings program. “The [D.C. District] court ruling made clear that HRSA does have regulatory authority that includes (1) establishing and implementing a binding Administrative Dispute Resolution process for the resolution of certain disputes relating to compliance with 340B Program requirements, (2) providing for the imposition of civil monetary penalties against manufacturers that knowingly and intentionally overcharge a covered entity for a 340B drug, and (3) issuing precisely defined standards of methodology for calculation of 340B ceiling prices,” the leaders wrote. 

Related News Articles

Headline
AHA urges HRSA to act as Eli Lilly threatens 340B discounts over claims data submission policy
The AHA again is asking the Health Resources and Services Administration to take action after Eli Lilly warned hospitals that they could lose access to…
Headline
Washington Post publishes AHA letter in response to anti-340B editorial
The Washington Post yesterday published a letter to the editor from AHA President and CEO Rick Pollack responding to an April 18 editorial criticizing the 340B…
Headline
AHA urges HRSA to abandon 340B rebate model that will cost billions and jeopardize access to care for millions
The Health Resources and Services Administration should abandon its consideration of a 340B rebate model pilot program because “a rebate mechanism of any kind…
Headline
AHA urges en banc review of 4th Circuit’s West Virginia 340B contract pharmacy law decision
The AHA and others April 17 filed an amicus brief requesting the U.S. Court of Appeals for the 4th Circuit grant en banc review of a panel decision that…
Headline
Mississippi 340B law upheld by appeals court in two cases
The U.S. Court of Appeals for the 5th Circuit April 9 affirmed rulings by a Mississippi district court that rejected requests by Novartis and PhRMA to enjoin…
Headline
Court strikes HRSA 340B policy restricting initial hospital drug purchases through GPOs
The U.S. District Court for the District of Columbia March 31 vacated a Health Resources and Services Administration policy instituted in 2013 that restricted…